Seven Eight Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Seven Eight Capital’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,765	Closed	-$602K	–	673
2022 Q3	$602K	Buy	+12,765	New	+$824K	0.12%	237
2021 Q4	–	Sell	-7,600	Closed	-$665K	–	721
2021 Q3	$665K	Buy	+7,600	New	+$688K	0.06%	381
2020 Q2	–	Sell	-7,700	Closed	-$304K	–	604
2020 Q1	$304K	Buy	7,700 +4,220	+121%	+$247K	0.08%	310
2019 Q4	$207K	Sell	3,480 -8,400	-71%	-$452K	0.01%	602
2019 Q3	$632K	Buy	+11,880	New	+$610K	0.03%	489
2019 Q2	–	Sell	-20,711	Closed	-$1.07M	–	780
2019 Q1	$1.07M	Sell	20,711 -14,230	-41%	-$690K	0.06%	353
2018 Q4	$1.38M	Buy	34,941 +28,600	+451%	+$1.33M	0.08%	306
2018 Q3	$327K	Buy	+6,341	New	+$310K	0.02%	505
2017 Q3	–	Sell	-800	Closed	-$47K	–	657
2017 Q2	$47K	Sell	800 -5,600	-88%	-$291K	0.01%	484
2017 Q1	$293K	Buy	+6,400	New	+$318K	0.06%	334
2016 Q4	–	Sell	-5,400	Closed	-$241K	–	662
2016 Q3	$241K	Buy	5,400 +3,700	+218%	+$160K	0.07%	300
2016 Q2	$65K	Buy	+1,700	New	+$74.7K	0.02%	433

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Seven Eight Capital's SYNH Position: Q4 2022 in Review

Seven Eight Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 12,765 shares — an estimated $602K sold.

Seven Eight Capital first reported a position in SYNH in Q2 2016 and held it in 12 quarters. The position peaked at $1.38M in Q4 2018. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Seven Eight Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Seven Eight Capital sold 12,765 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $602K.
Seven Eight Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2016 and held it in 12 quarters.
Seven Eight Capital's Syneos Health, Inc. Class A Common Stock position peaked at $1.38M in Q4 2018.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Seven Eight Capital's 13F filing for Q4 2022, filed 13 Feb 2023.